Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Therapies

Cancer Therapies

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Targeted Cancer Therapies

Targeted Cancer Therapies

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer.

Nature reviews. Clinical oncology·2026

Same author

Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet Study.

Clinical lung cancer·2026

Same author

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.

European journal of cancer (Oxford, England : 1990)·2026

Same author

Spatial proteomics profiling reveals oncogene-specific immune niches and prognostic markers in NSCLC.

American journal of respiratory and critical care medicine·2026

Same author

Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

IRG1/itaconate rewires macrophage and lung tumor metabolism through G6PD inhibition.

Cell metabolism·2026

Same journal

Clinical Rationale and Indications for Particle Therapy.

Progress in tumor research·2024

Same journal

Advances in Radiation Biology of Particle Irradiation.

Progress in tumor research·2024

Same journal

Imageable Biomarkers for Radiotherapy Response.

Progress in tumor research·2024

Same journal

Stereotactic Body Radiotherapy.

Progress in tumor research·2024

Same journal

Imaging for Target Volume Definition and Response Assessment in Lung Cancer.

Progress in tumor research·2024

Same journal

Principles and Developments in Cancer Immunotherapy and Approaches for Combination with Tumour Irradiation.

Progress in tumor research·2024

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 3, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Combinations Therapies.

Niels Reinmuth, Martin Reck

Progress in Tumor Research

|September 19, 2015

Summary

This summary is machine-generated.

Cancer immunotherapy combinations show promise for lung cancer, enhancing immune response. However, increased toxic side effects necessitate careful patient selection and new clinical trial designs for combinatorial cancer treatments.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Related Experiment Videos

Last Updated: Apr 3, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Area of Science:

Oncology
Immunology
Pharmacology

Background:

Cancer immunotherapy utilizes strategies to boost the immune response against tumors.
Initial clinical studies show promise for immunomodulating monotherapies in lung cancer.
Combinatorial approaches are being explored to enhance therapeutic benefits.

Purpose of the Study:

To explore synergistic combinations of immunotherapies and other agents for improved cancer treatment.
To investigate the efficacy and safety of combining different immunotherapy mechanisms or agents.
To assess the potential of combinatorial immunotherapy to alter cancer treatment paradigms.

Main Methods:

Review of clinical studies and animal models investigating immunotherapy combinations.
Analysis of simultaneous blockade of immune checkpoints like PD-1 and CTLA-4.
Evaluation of combinations of immunomodulators with chemotherapy or targeted therapies.

Main Results:

Immunotherapy combinations, including PD-1/CTLA-4 blockade, demonstrate therapeutic synergy.
Animal models suggest synergistic effects for various immunotherapy combinations.
Combinations show potential to revolutionize cancer treatment across all disease stages.

Conclusions:

Combinatorial immunotherapy offers significant potential for lung cancer treatment but potentiates toxic side effects.
Careful patient selection and novel clinical development strategies are required for combinatorial immunotherapy.
Further research is needed to fully appreciate the impact of combinatorial manipulation on tumor and stromal cells.